CTMX Cytomx Therapeutics, Inc.

$2.96 +0.00%

Healthcare · Pharmaceutical Preparations

Cytomx Therapeutics, Inc. (CTMX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $643 million. Shares last traded at $2.96, 64.0% below their 52-week high. Over the past year the stock is up 23.6%. Net profit margin is -22.8%, below the peer median of -0.1%. Revenue declined 44.8% year over year.

Market Cap

$643M

Shares Out

217.7M

EPS (TTM)

—

P/E Ratio

—

P/S Ratio

8.44

P/B Ratio

2.01

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.20

52-Week Low

$1.73

Volume

185,357

Avg Vol (3m)

208,420.333

Performance

-0.51%

-19.04%

-38.18%

-30.31%

YTD

-30.47%

+23.64%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

31.67

SMA (50)

$3.82

SMA (200)

$4.06

Price vs SMA50

-22.55%

Price vs SMA200

-27.18%

ATR (14)

$0.18

Financials

Revenue

$76M

Net Income

$-17M

Gross Margin

—

Operating Margin

-29.3%

Net Margin

-22.8%

Return on Equity

-5.4%

Return on Assets

-4.8%

Current Ratio

10.38

Debt / Equity

0.00

Revenue Growth (YoY)

-44.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Pharmaceutical Preparations peers

CTMX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

8.44 / 3.54 med

+139% premium

Net margin vs peers

-22.8% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.